Jian-xu Li
Nanning, 530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Risk Factors of Non-Classic Radiation-Induced Liver Disease (ncRILD) After Intensity-Modulated Radiotherapy in Hepatocellular Carcinoma.
Journal: Cancer management and research
Published: May 10, 2025
Radiation-induced hepatic toxicity from radiotherapy plus immune checkpoint inhibitors with targeted therapy in HCC patients: a propensity score-matched study.
Journal: Radiation oncology (London, England)
Published: February 18, 2024
Radiotherapy plus anti-PD1 versus radiotherapy for hepatic toxicity in patients with hepatocellular carcinoma.
Journal: Radiation oncology (London, England)
Published: September 22, 2022
Non-classic radiation-induced liver disease after intensity-modulated radiotherapy for Child-Pugh grade B patients with locally advanced hepatocellular carcinoma.
Journal: Radiation oncology (London, England)
Published: June 18, 2022
Prognostic value of a nomogram based on peripheral blood immune parameters in unresectable hepatocellular carcinoma after intensity-modulated radiotherapy.
Journal: BMC gastroenterology
Published: June 07, 2022
New Staging Model for Radiation-based Hepatocellular Carcinoma Treatment: A National Multicenter Study.
Journal: Journal of clinical and translational hepatology
Published: January 01, 2022
Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world study.
Journal: Radiation oncology (London, England)
Published: December 22, 2021
A Prospective Study of Liver Regeneration After Radiotherapy Based on a New (Su'S) Target Area Delineation.
Journal: Frontiers in oncology
Published: March 14, 2021
Long-Term Survival Analysis of Transarterial Chemoembolization Plus Radiotherapy vs. Radiotherapy for Hepatocellular Carcinoma With Macroscopic Vascular Invasion.
Journal: Frontiers in oncology
Published: January 11, 2020
Letter: are sorafenib-related adverse events associated with prolonged survival?
Journal: Alimentary pharmacology & therapeutics
Published: December 19, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026